NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 383 filers reported holding NEKTAR THERAPEUTICS in Q2 2018. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $181,000 | -60.2% | 9,078 | -35.6% | 0.04% | -62.6% |
| Q2 2019 | $455,000 | +3.6% | 14,093 | +2.9% | 0.11% | 0.0% |
| Q1 2019 | $439,000 | -24.4% | 13,699 | +0.8% | 0.11% | -30.5% |
| Q4 2018 | $581,000 | +33.6% | 13,585 | +24.7% | 0.15% | +29.4% |
| Q3 2018 | $435,000 | -36.0% | 10,895 | -3.9% | 0.12% | -35.3% |
| Q2 2018 | $680,000 | +84.3% | 11,335 | +66.4% | 0.18% | +82.2% |
| Q1 2018 | $369,000 | -14.4% | 6,813 | -62.8% | 0.10% | -24.6% |
| Q3 2017 | $431,000 | – | 18,300 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
| GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
| Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
| Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
| Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
| CM Management, LLC | 50,000 | $160,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
| PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
| Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |
| ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |